Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial-Reference-Cited by-同舟云学术

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

Published:2008-11 Issue:11 Volume:58 Page:3402-3412
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Inman Robert D.,Davis John C.,Heijde Désirée Van Der,Diekman Laura,Sieper Joachim,Kim Sung Il,Mack Michael,Han John,Visvanathan Sudha,Xu Zhenhua,Hsu Benjamin,Beutler Anna,Braun Jürgen

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference20 articles.

1. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis;Braun;Arthritis Rheum,1995

2. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial;Davis;Arthritis Rheum,2003

3. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT);Van der Heijde;Arthritis Rheum,2005

4. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial;Van der Heijde;Arthritis Rheum,2006

5. Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study;Kay;Arthritis Rheum,2008

Cited by 484 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol;BMJ Open;2024-09

2. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

3. Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies;Expert Review of Clinical Immunology;2024-07-29

4. Axial spondyloarthritis—current aspects;Exploration of Musculoskeletal Diseases;2024-07-24

5. The Use of TNF-α Inhibitors in Active Ankylosing Spondylitis Treatment;Cureus;2024-06-01